Will JHX reduce net leverage below 2.5x by Q2 FY2027 (December 2026)?

Reaching 2.5x by December 2026 requires reducing net debt from $4.3B to ~$3.1B — a $1.2B reduction in roughly 3-4 quarters. With FY26 FCF at only ~$200M and FY27 FCF likely improving but unlikely to reach $500M immediately, the math is extremely challenging. Even with $400-500M FCF in FY27 and declining CapEx, reducing $1.2B of net debt requires either a dramatic EBITDA expansion or asset sales not currently discussed. The 2.5x target by December 2026 appears aggressive given current cash generation.

The leverage math is straightforward: net debt $4.3B / $1.25B EBITDA = 3.0x currently. To reach 2.5x by Q2 FY27, either EBITDA must increase to ~$1.72B (net debt $4.3B / 2.5x) or net debt must fall to ~$3.1B with flat EBITDA. Neither scenario is plausible by December 2026. EBITDA growing from $1.25B to $1.72B requires 38% growth in one year — impossible. Net debt declining $1.2B requires FCF well above current trajectory. Management's own target is sub-2x by mid-2027, suggesting they view 2.5x as an intermediate step that may not be achieved until early-to-mid 2027.

While the headline math is challenging, there are upside paths: (1) if housing starts recover meaningfully, FY27 EBITDA could reach $1.4-1.5B, bringing the leverage denominator up significantly; (2) declining CapEx and lower integration costs could free $300-400M FCF in the first 3 quarters of FY27; (3) plant closures add $25M of savings. But even optimistically, reaching 2.5x by Q2 FY27 requires a perfect scenario. The EBITDA expansion would need to be substantial to bring leverage from 3.0x to 2.5x in 3 quarters, and housing recovery is uncertain.

The arithmetic is unforgiving. Net debt needs to decline from $4.3B to ~$3.1B in 9 months, while the company generates only ~$200M annual FCF. Even doubling FCF in FY27 to $400M, only $200-250M would flow to debt reduction by December 2026 (half the fiscal year). That brings net debt to ~$4.0B, giving leverage of ~2.9x — still far from 2.5x. EBITDA would need to simultaneously jump to $1.6B+ for the denominator effect. This is an unrealistic target for the stated timeframe.

Management committed to below 2x within 2 years (by mid-2027), which implies they see a path to rapid deleveraging. But 2.5x by December 2026 is an intermediate milestone that management has not specifically committed to. The path would require both EBITDA expansion to ~$1.4B+ AND meaningful debt paydown of $300-400M. Cost synergies and plant closures help on the EBITDA side, but housing recovery is the wildcard. Without housing improvement, this target is very difficult to achieve.

Even with optimistic assumptions — FY27 EBITDA at $1.35B (8% growth from synergies + organic recovery) and $300M debt paydown by December 2026 (bringing net debt to $4.0B) — leverage would be $4.0B / $1.35B LTM = 2.96x. To reach 2.5x would require net debt of $3.375B (implying $925M reduction) with that EBITDA. The only way this works is if there's a non-operating cash event (asset sale, working capital release) that I'm not seeing in the analysis. Probability is low.

Net debt reduction of $1.2B in 9 months is too aggressive given ~$200M annual FCF. Even with improving FCF trajectory in FY27, the math doesn't work for a December 2026 target. Management's own sub-2x target is mid-2027, suggesting 2.5x is a late-FY27 milestone at best.

Simple math: $4.3B net debt, $1.25B EBITDA = 3.0x. To reach 2.5x by Dec 2026, need net debt below $3.1B or EBITDA above $1.72B. Neither achievable in 3 quarters. Very unlikely.

Deleveraging will happen but not this fast. The combination of synergies, declining CapEx, and organic recovery should bring leverage down over time, but 2.5x by December 2026 requires a pace of improvement that exceeds what the financial trajectory supports. More realistic target is mid-to-late 2027.